☰

Melissa A. Culhane, Ph.D. - Publications

Affiliations: 
2009 Boston University, Boston, MA, United States 
Area:
Cultural Anthropology, Clinical Psychology, Public Health
Tree Info Similar researchers PubMed Report error

0/20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2010 Janes AC, Pizzagalli DA, Richardt S, deB Frederick B, Chuzi S, Pachas G, Culhane MA, Holmes AJ, Fava M, Evins AE, Kaufman MJ. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biological Psychiatry. 67: 722-9. PMID 20172508 DOI: 10.1016/J.Biopsych.2009.12.034  0.01
2009 Cohen MH, Fabri M, Cai X, Shi Q, Hoover DR, Binagwaho A, Culhane MA, Mukanyonga H, Karegeya DK, Anastos K. Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women. Journal of Women's Health (2002). 18: 1783-91. PMID 19951212 DOI: 10.1089/jwh.2009.1367  0.01
2009 Goff DC, Cather C, Freudenreich O, Henderson DC, Evins AE, Culhane MA, Walsh JP. A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Psychopharmacology. 202: 411-7. PMID 18716761 DOI: 10.1007/S00213-008-1278-5  0.01
2008 Culhane MA, Schoenfeld DA, Barr RS, Cather C, Deckersbach T, Freudenreich O, Goff DC, Rigotti NA, Evins AE. Predictors of early abstinence in smokers with schizophrenia. The Journal of Clinical Psychiatry. 69: 1743-50. PMID 19026259 DOI: 10.4088/Jcp.V69N1109  0.01
2008 Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Journal of Clinical Psychopharmacology. 28: 660-6. PMID 19011435 DOI: 10.1097/Jcp.0B013E31818Ad7D6  0.01
2008 Dyer MA, Freudenreich O, Culhane MA, Pachas GN, Deckersbach T, Murphy E, Goff DC, Evins AE. High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophrenia Research. 102: 88-95. PMID 18325740 DOI: 10.1016/J.Schres.2007.12.491  0.01
2008 Loebl T, Angarita GA, Pachas GN, Huang KL, Lee SH, Nino J, Logvinenko T, Culhane MA, Evins AE. A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men. The Journal of Clinical Psychiatry. 69: 480-6. PMID 18294021 DOI: 10.4088/JCP.V69N0321  0.01
2008 Barr RS, Pizzagalli DA, Culhane MA, Goff DC, Evins AE. A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence. Biological Psychiatry. 63: 1061-5. PMID 17976537 DOI: 10.1016/J.Biopsych.2007.09.015  0.01
2008 Pizzagalli DA, Evins AE, Schetter EC, Frank MJ, Pajtas PE, Santesso DL, Culhane M. Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology. 196: 221-32. PMID 17909750 DOI: 10.1007/s00213-007-0957-y  0.01
2008 Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 480-90. PMID 17443126 DOI: 10.1038/Sj.Npp.1301423  0.01
2007 Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology. 27: 380-6. PMID 17632223 DOI: 10.1097/01.Jcp.0B013E3180Ca86Fa  0.01
2007 Freudenreich O, Henderson DC, Walsh JP, Culhane MA, Goff DC. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial. Schizophrenia Research. 92: 90-4. PMID 17321111 DOI: 10.1016/J.Schres.2006.12.030  0.01
2006 Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A, Freudenreich O, Taber SM, Goff DC. Dietary intake profile of patients with schizophrenia. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 18: 99-105. PMID 16754415 DOI: 10.1080/10401230600614538  0.01
2006 Eden Evins A, Demopulos C, Yovel I, Culhane M, Ogutha J, Grandin LD, Nierenberg AA, Sachs GS. Inositol augmentation of lithium or valproate for bipolar depression. Bipolar Disorders. 8: 168-74. PMID 16542187 DOI: 10.1111/J.1399-5618.2006.00303.X  0.01
2006 Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. Bipolar Disorders. 8: 75-80. PMID 16411983 DOI: 10.1111/J.1399-5618.2006.00243.X  0.01
2005 Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. The Journal of Clinical Psychiatry. 66: 1184-90. PMID 16187778 DOI: 10.4088/Jcp.V66N0915  0.01
2005 Henderson DC, Mollica RF, Tor S, Lavelle J, Culhane MA, Hayden D. Building primary care practitioners' attitudes and confidence in mental health skills in a post-conflict society: a Cambodian example. The Journal of Nervous and Mental Disease. 193: 551-9. PMID 16082300 DOI: 10.1097/01.nmd.0000172869.01711.33  0.01
2005 Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology. 25: 218-25. PMID 15876899 DOI: 10.1097/01.Jcp.0000162802.54076.18  0.01
2003 Rettew DC, Zanarini MC, Yen S, Grilo CM, Skodol AE, Shea MT, McGlashan TH, Morey LC, Culhane MA, Gunderson JG. Childhood antecedents of avoidant personality disorder: a retrospective study. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 1122-30. PMID 12960713 DOI: 10.1097/01.Chi.0000070250.24125.5F  0.01
1999 Eisen SV, Wilcox M, Leff HS, Schaefer E, Culhane MA. Assessing behavioral health outcomes in outpatient programs: Reliability and validity of the BASIS-32 Journal of Behavioral Health Services and Research. 26: 5-17. PMID 10069137 DOI: 10.1007/Bf02287790  0.01
Hide low-probability matches.